Hiromi Maruyama
Family Medicine · Sanford, NCNPI 1013181775
Payments from drug & device makers
Across 356 payments — averaging $23.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$2K
- Amgen$557
- AbbVie$510
- Biohaven Pharmaceuticals, Inc.$467
- Lilly USA, LLC$462
- plus $2K from 35 others
What the payments were for
- Food & beverage$8,382100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 105 | $2,461 |
| AstraZeneca | 41 | $1,696 |
| Amgen | 25 | $557 |
| AbbVie | 32 | $510 |
| Biohaven Pharmaceuticals, Inc. | 2 | $467 |
| Lilly USA, LLC | 33 | $462 |
| Pfizer | 15 | $261 |
| Amarin Pharma, Inc. | 9 | $183 |
| Boehringer Ingelheim | 10 | $181 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $175 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $170 |
| Merck | 9 | $134 |
| Sanofi-aventis U.S. LLC | 6 | $126 |
| Ironwood Pharmaceuticals, Inc | 5 | $100 |
| Abbott | 5 | $92 |
| Exact Sciences | 4 | $88 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Hologic Sales And Service, LLC | 3 | $58 |
| GSK | 4 | $56 |
| Novartis | 3 | $52 |
| Johnson & Johnson | 3 | $50 |
| Sanofi Pasteur Inc. | 1 | $49 |
| Bayer | 2 | $39 |
| Nestle Healthcare Nutrition Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 2 | $29 |
| Gilead | 1 | $27 |
| Philips North America LLC | 2 | $22 |
| Axonics, Inc. | 1 | $21 |
| Medtronic | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Insulet Corporation | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Organon | 1 | $13 |
| Sobi, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,382 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 90 | $111,209 |
| JardianceEmpagliflozin | 62 | $85,427 |
| FarxigaDapagliflozin Propanediol | 41 | $56,885 |
| TrulicityDulaglutide | 16 | $19,676 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $19,604 |
| EliquisApixaban | 27 | $19,284 |
| Varenicline Tartrate | 34 | $10,453 |
| Repatha SureclickEvolocumab | 14 | $10,287 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,596 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $7,222 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 56 | $5,713 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $2,294 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 81 | $2,142 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 21 | $1,437 |
| Gabapentin | 72 | $1,413 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $2,461 | $111,20990 claims |
| Boehringer IngelheimJardiance | $181 | $85,42762 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,696 | $64,48153 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $56 | $26,82643 claims |
| Lilly USA, LLCTrulicity | $462 | $19,67616 claims |
| PfizerEliquis | $261 | $19,28427 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $14 | $71562 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Sanford
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.